000 01208 a2200325 4500
005 20250513052048.0
264 0 _c19941123
008 199411s 0 0 eng d
022 _a0279-1072
024 7 _a10.1080/02791072.1994.10472267
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMcCarthy, J
245 0 0 _aQuantitative urine drug monitoring in methadone programs: potential clinical uses.
_h[electronic resource]
260 _bJournal of psychoactive drugs
_c
300 _a199-206 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAmphetamine
_xurine
650 0 4 _aCocaine
_xurine
650 0 4 _aFluorescence Polarization Immunoassay
650 0 4 _aHumans
650 0 4 _aLegislation, Medical
650 0 4 _aMethadone
_xtherapeutic use
650 0 4 _aNarcotics
_xurine
650 0 4 _aOpioid-Related Disorders
_xrehabilitation
650 0 4 _aQuality Assurance, Health Care
650 0 4 _aSubstance Abuse Detection
650 0 4 _aSubstance-Related Disorders
_xcomplications
773 0 _tJournal of psychoactive drugs
_gvol. 26
_gno. 2
_gp. 199-206
856 4 0 _uhttps://doi.org/10.1080/02791072.1994.10472267
_zAvailable from publisher's website
999 _c7931202
_d7931202